Pfizer Says Its Vaccine Is 90.7% Effective Against Symptomatic COVID-19 In Children Ages 5 To 11
In a new document posted ahead of a key meeting of the US Food and Drug Administration's vaccine advisers, Pfizer says its vaccine is safe and 90.7% effective against symptomatic COVID-19 in children ages 5 to 11.